+ Site Statistics
+ Search Articles
+ Subscribe to Site Feeds
EurekaMag Most Shared ContentMost Shared
EurekaMag PDF Full Text ContentPDF Full Text
+ PDF Full Text
Request PDF Full TextRequest PDF Full Text
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter
Follow on LinkedInFollow on LinkedIn

+ Translate

TORCH testing in HIV-infected women

TORCH testing in HIV-infected women

Clinical Obstetrics and Gynecology 42(1): 149-62; Quiz 174-5

Screening for TORCH (Toxoplasma gondii, rubella, cytomegalovirus and herpes simplex) infections in HIV-infected pregnant women is reviewed. It is recommended that prenatal patients with newly diagnosed HIV infection should be tested for T. gondii IgG antibodies; if positive, IgM antibodies should be obtained in an attempt to rule out acute T. gondii infection.

(PDF emailed within 1 workday: $29.90)

Accession: 003292397

Download citation: RISBibTeXText

PMID: 10073308

Related references

Estimation of fetus condition in women infected with different TORCH infections. Uzbekiston Tibbiet Zhurnali (1): 50-51, 2001

The effect of immunodeficiency on cutaneous delayed-type hypersensitivity testing in HIV-infected women without anergy: implications for tuberculin testing. HER Study Group. HIV Epidemiology Research. International Journal of Tuberculosis and Lung Disease 3(8): 681-688, 1999

How to use... neonatal TORCH testing. Archives of Disease in Childhood. Education and Practice Edition 98(3): 93-98, 2013

Barriers and pathways to testing among HIV-infected women. Aids Education and Prevention 10(2): 114-127, 1998

Gonadotropin and sex steroid levels in HIV-infected premenopausal women and their association with subclinical atherosclerosis in HIV-infected and -uninfected women in the women's interagency HIV study (WIHS). Journal of Clinical Endocrinology and Metabolism 98(4): E610-E618, 2013

Oxyacetylene torch testing and microstructural characterization of tantalum carbide. Journal of Microscopy 250(2): 122-129, 2013

Risk factors for nonadherence with Pap testing in HIV-infected women. Journal of Women's Health 20(11): 1635-1643, 2012

TORCH agents in pregnant Saudi women. Medical Principles and Practice 11(4): 180-182, 2002

Pet feeding and TORCH infection in pregnant women. Chinese Journal of Zoonoses 19(1): 129, 104, 2003

Minimally abnormal Pap testing and cervical histology in HIV-infected women. Journal of Women's Health 21(1): 87-91, 2012

Factors associated with time to colposcopy after abnormal Pap testing in HIV-infected women. Journal of Women's Health 21(4): 418-424, 2012

Tuberculin skin testing among pregnant, HIV-infected women, Miami, FL, USA. Abstracts of the Interscience Conference on Antimicrobial Agents & Chemotherapy 38: 408, 1998

Evaluation of testing strategies to identify infected animals at a single round of testing within dairy herds known to be infected with Mycobacterium avium ssp. paratuberculosis. Journal of Dairy Science 98(8): 5194-5210, 2016

Seroprevalence of TORCH infections in women of childbearing age in Croatia. Journal of Maternal-Fetal & Neonatal Medicine 24(2): 280-283, 2011

Kato carries the torch for women worldwide. Japan. Joicfp News: 4-4, 2002